Exane BNP Paribas analyst Ian Pearce downgraded Scor (SCRYY) to Neutral from Outperform with a EUR 26 price target The company’s capital generation is disappointing, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCRYY:
- Scor price target lowered to EUR 27.30 from EUR 28 at UBS
- Scor upgraded to Overweight from Equal Weight at Morgan Stanley
- Scor upgraded to Neutral from Underweight at JPMorgan
- Scor price target raised to EUR 24.40 from EUR 21.40 at Citi
- Scor upgraded to Outperform from Market Perform at Keefe Bruyette